{
    "Trade/Device Name(s)": [
        "BBL Sensi-Disc Antimicrobial Susceptibility Test Disks, Gemifloxacin 5\u03bcg",
        "GEMIFLOXACIN 5\u03bcg, BBL Sensi-Disc Antimicrobial Susceptibility Test Disks"
    ],
    "Submitter Information": "Becton Dickinson and Company",
    "510(k) Number": "K050062",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JTN"
    ],
    "Summary Letter Date": "February 1, 2005",
    "Summary Letter Received Date": "January 11, 2005",
    "Submission Date": "January 5, 2005",
    "Regulation Number(s)": [
        "21 CFR 866.1620"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Disks"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Gemifloxacin"
    ],
    "Specimen Type(s)": [
        "Pure cultures of clinical isolates (bacteria)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Agar diffusion susceptibility test",
        "Disk diffusion"
    ],
    "Methodologies": [
        "Standardized agar diffusion",
        "Bauer-Kirby method"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Disk",
        "Consumable"
    ],
    "Document Summary": "FDA 510(k) summary for BBL Sensi-Disc Antimicrobial Susceptibility Test Disks, Gemifloxacin 5\u03bcg for in vitro bacterial susceptibility testing using agar diffusion.",
    "Indications for Use Summary": "For in vitro agar diffusion susceptibility testing to determine the susceptibility of bacteria to Gemifloxacin.",
    "fda_folder": "Microbiology"
}